• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成相关扩散成像高信号可勾画临床显著前列腺癌。

Synthetic correlated diffusion imaging hyperintensity delineates clinically significant prostate cancer.

机构信息

Department of Systems Design Engineering, University of Waterloo, Waterloo, Canada.

Ontario Institute for Cancer Research, Toronto, Canada.

出版信息

Sci Rep. 2022 Mar 1;12(1):3376. doi: 10.1038/s41598-022-06872-7.

DOI:10.1038/s41598-022-06872-7
PMID:35232991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8888633/
Abstract

Prostate cancer (PCa) is the second most common cancer in men worldwide and the most frequently diagnosed cancer among men in more developed countries. The prognosis of PCa is excellent if detected at an early stage, making early screening crucial for detection and treatment. In recent years, a new form of diffusion magnetic resonance imaging called correlated diffusion imaging (CDI) was introduced, and preliminary results show promise as a screening tool for PCa. In the largest study of its kind, we investigate the relationship between PCa presence and a new variant of CDI we term synthetic correlated diffusion imaging (CDI[Formula: see text]), as well as its performance for PCa delineation compared to current standard MRI techniques [T2-weighted (T2w) imaging, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE) imaging] across a cohort of 200 patient cases. Statistical analyses reveal that hyperintensity in CDI[Formula: see text] is a strong indicator of PCa presence and achieves strong delineation of clinically significant cancerous tissue compared to T2w, DWI, and DCE. These results suggest that CDI[Formula: see text] hyperintensity may be a powerful biomarker for the presence of PCa, and may have a clinical impact as a diagnostic aid for improving PCa screening.

摘要

前列腺癌(PCa)是全球男性第二大常见癌症,也是较发达国家男性中最常见的癌症。如果在早期发现,PCa 的预后非常好,因此早期筛查对于检测和治疗至关重要。近年来,一种称为相关扩散成像(CDI)的新型扩散磁共振成像形式被引入,初步结果显示其作为 PCa 筛查工具具有潜力。在同类研究中规模最大的一项研究中,我们研究了 PCa 存在与我们称之为合成相关扩散成像(CDI[公式:见文本])的 CDI 新变体之间的关系,以及与当前标准 MRI 技术(T2 加权成像(T2w)、扩散加权成像(DWI)和动态对比增强(DCE)成像)相比,该变体在 200 例患者队列中对 PCa 进行描绘的性能。统计分析表明,CDI[公式:见文本]中的高信号是 PCa 存在的强烈指标,与 T2w、DWI 和 DCE 相比,其对临床显著癌组织的描绘能力较强。这些结果表明,CDI[公式:见文本]中的高信号可能是 PCa 存在的有力生物标志物,并且可能具有临床影响,作为改善 PCa 筛查的诊断辅助工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/8888633/b022ec90d84d/41598_2022_6872_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/8888633/40bece9f3e12/41598_2022_6872_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/8888633/33e5b9bf9a01/41598_2022_6872_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/8888633/09ca01919006/41598_2022_6872_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/8888633/b022ec90d84d/41598_2022_6872_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/8888633/40bece9f3e12/41598_2022_6872_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/8888633/33e5b9bf9a01/41598_2022_6872_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/8888633/09ca01919006/41598_2022_6872_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/8888633/b022ec90d84d/41598_2022_6872_Fig4_HTML.jpg

相似文献

1
Synthetic correlated diffusion imaging hyperintensity delineates clinically significant prostate cancer.合成相关扩散成像高信号可勾画临床显著前列腺癌。
Sci Rep. 2022 Mar 1;12(1):3376. doi: 10.1038/s41598-022-06872-7.
2
Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?多参数 MRI 对高强度聚焦超声治疗后疑似复发性前列腺癌的应用:DCE 仍有必要吗?
Eur Radiol. 2018 Sep;28(9):3760-3769. doi: 10.1007/s00330-018-5352-z. Epub 2018 Apr 9.
3
Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.T2 加权成像、DWI 和动态对比增强 MRI 计算前列腺癌指数病变体积的比较:与全切片病理的相关性。
AJR Am J Roentgenol. 2019 Feb;212(2):351-356. doi: 10.2214/AJR.18.20147. Epub 2018 Dec 12.
4
Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?多参数磁共振成像(MRI)上显著前列腺癌的可视性——我们仍然需要造影剂吗?
Eur Radiol. 2021 Jun;31(6):3754-3764. doi: 10.1007/s00330-020-07494-1. Epub 2020 Dec 2.
5
Diagnostic performance of diffusion-weighted imaging combined with dynamic contrast-enhanced magnetic resonance imaging for prostate cancer: a systematic review and meta-analysis.扩散加权成像联合动态对比增强磁共振成像对前列腺癌的诊断性能:系统评价和荟萃分析。
Acta Radiol. 2021 Sep;62(9):1238-1247. doi: 10.1177/0284185120956269. Epub 2020 Sep 9.
6
Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI study.比较腔内水成像与扩散加权和动态对比增强 MRI 在前列腺癌中的诊断准确性:一项定量 MRI 研究。
NMR Biomed. 2019 Feb;32(2):e4048. doi: 10.1002/nbm.4048. Epub 2018 Dec 21.
7
Multiparametric MRI in detection and staging of prostate cancer.多参数磁共振成像在前列腺癌检测与分期中的应用
Dan Med J. 2017 Feb;64(2).
8
Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.多参数 MRI 与自动固定感兴趣区的放射组学特征在临床显著的外周带前列腺癌中的应用。
Eur Radiol. 2020 Mar;30(3):1313-1324. doi: 10.1007/s00330-019-06488-y. Epub 2019 Nov 27.
9
Utility of Quantitative T2-Mapping Compared to Conventional and Advanced Diffusion Weighted Imaging Techniques for Multiparametric Prostate MRI in Men with Hip Prosthesis.定量 T2 映射技术在髋关节假体男性患者多参数前列腺 MRI 中的应用价值:与常规和高级扩散加权成像技术的比较。
J Magn Reson Imaging. 2022 Jan;55(1):265-274. doi: 10.1002/jmri.27803. Epub 2021 Jul 5.
10
Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.放射性治疗后前列腺癌局部复发的动态对比增强成像:对不同经验水平的读者的附加价值有限。
J Magn Reson Imaging. 2018 Oct;48(4):1012-1023. doi: 10.1002/jmri.25991. Epub 2018 Mar 8.

引用本文的文献

1
Optimized Synthetic Correlated Diffusion Imaging for Improving Breast Cancer Tumor Delineation.用于改善乳腺癌肿瘤轮廓描绘的优化合成相关扩散成像
Sensors (Basel). 2024 Dec 21;24(24):8173. doi: 10.3390/s24248173.
2
Feasibility of diffusion-tensor and correlated diffusion imaging for studying white-matter microstructural abnormalities: Application in COVID-19.弥散张量和相关弥散成像在研究脑白质微观结构异常中的可行性:在 COVID-19 中的应用。
Hum Brain Mapp. 2023 Jul;44(10):3998-4010. doi: 10.1002/hbm.26322. Epub 2023 May 10.
3
Skin Cancer Pathobiology at a Glance: A Focus on Imaging Techniques and Their Potential for Improved Diagnosis and Surveillance in Clinical Cohorts.

本文引用的文献

1
Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging.利用弥散加权和 T2 加权成像的全病变直方图和纹理分析鉴别前列腺癌与良性前列腺增生。
Cancer Imaging. 2021 Sep 27;21(1):54. doi: 10.1186/s40644-021-00423-5.
2
Quality control and whole-gland, zonal and lesion annotations for the PROSTATEx challenge public dataset.用于 PROSTATEx 挑战赛公共数据集的质量控制以及整个腺体、区域和病变标注。
Eur J Radiol. 2021 May;138:109647. doi: 10.1016/j.ejrad.2021.109647. Epub 2021 Mar 10.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
皮肤癌病理生物学速览:聚焦影像学技术及其在临床队列中改善诊断和监测的潜力。
Int J Mol Sci. 2023 Jan 5;24(2):1079. doi: 10.3390/ijms24021079.
4
MEDUSA: Multi-Scale Encoder-Decoder Self-Attention Deep Neural Network Architecture for Medical Image Analysis.MEDUSA:用于医学图像分析的多尺度编码器-解码器自注意力深度神经网络架构
Front Med (Lausanne). 2022 Feb 15;8:821120. doi: 10.3389/fmed.2021.821120. eCollection 2021.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Array programming with NumPy.使用 NumPy 进行数组编程。
Nature. 2020 Sep;585(7825):357-362. doi: 10.1038/s41586-020-2649-2. Epub 2020 Sep 16.
5
Diagnostic Performance of PET Imaging Using Different Radiopharmaceuticals in Prostate Cancer According to Published Meta-Analyses.根据已发表的荟萃分析,不同放射性药物在前列腺癌中PET成像的诊断性能
Cancers (Basel). 2020 Aug 4;12(8):2153. doi: 10.3390/cancers12082153.
6
SciPy 1.0: fundamental algorithms for scientific computing in Python.SciPy 1.0:Python 中的科学计算基础算法。
Nat Methods. 2020 Mar;17(3):261-272. doi: 10.1038/s41592-019-0686-2. Epub 2020 Feb 3.
7
Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone.扩散加权成像对前列腺癌的诊断性能:外周带与移行带比较。
PLoS One. 2018 Jun 22;13(6):e0199636. doi: 10.1371/journal.pone.0199636. eCollection 2018.
8
DCE MRI of prostate cancer.前列腺癌的 DCE-MRI 研究。
Abdom Radiol (NY). 2016 May;41(5):844-53. doi: 10.1007/s00261-015-0589-3.
9
Prostate MRI based on PI-RADS version 2: how we review and report.基于前列腺影像报告和数据系统(PI-RADS)第2版的前列腺磁共振成像:我们的阅片与报告方式
Cancer Imaging. 2016 Apr 11;16:9. doi: 10.1186/s40644-016-0068-2.
10
PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.PI-RADS前列腺影像报告和数据系统:2015版,第2版
Eur Urol. 2016 Jan;69(1):16-40. doi: 10.1016/j.eururo.2015.08.052. Epub 2015 Oct 1.